200 related articles for article (PubMed ID: 8084407)
1. The lack of a role for p53 in astrocytomas in pediatric patients.
Litofsky NS; Hinton D; Raffel C
Neurosurgery; 1994 Jun; 34(6):967-72; discussion 972-3. PubMed ID: 8084407
[TBL] [Abstract][Full Text] [Related]
2. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
[TBL] [Abstract][Full Text] [Related]
3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J
Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
[TBL] [Abstract][Full Text] [Related]
5. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of p53 gene and protein alterations in human astrocytic tumors.
Louis DN; von Deimling A; Chung RY; Rubio MP; Whaley JM; Eibl RH; Ohgaki H; Wiestler OD; Thor AD; Seizinger BR
J Neuropathol Exp Neurol; 1993 Jan; 52(1):31-8. PubMed ID: 8381161
[TBL] [Abstract][Full Text] [Related]
7. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
8. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.
Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG
Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343
[TBL] [Abstract][Full Text] [Related]
9. Expression and mutation analysis of the p53 gene in astrocytoma.
Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
[TBL] [Abstract][Full Text] [Related]
10. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
[TBL] [Abstract][Full Text] [Related]
11. p53 and PTEN gene mutations in gemistocytic astrocytomas.
Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
[TBL] [Abstract][Full Text] [Related]
12. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
13. p53 protein in pediatric malignant astrocytomas: a study of 21 patients.
Bhattacharjee MB; Bruner JM
J Neurooncol; 1997 May; 32(3):225-33. PubMed ID: 9049884
[TBL] [Abstract][Full Text] [Related]
14. Timing of p53 mutations during astrocytoma tumorigenesis.
del Arco A; García J; Arribas C; Barrio R; Blázquez MG; Izquierdo JM; Izquierdo M
Hum Mol Genet; 1993 Oct; 2(10):1687-90. PubMed ID: 8268922
[TBL] [Abstract][Full Text] [Related]
15. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
[TBL] [Abstract][Full Text] [Related]
16. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of tumor suppressor genes p53, p21 WAF1/CIP1 and p27 KIP1 in humam astrocystic tumors.
Faria MH; Patrocínio RM; Moraes Filho MO; Rabenhorst SH
Arq Neuropsiquiatr; 2007 Dec; 65(4B):1114-22. PubMed ID: 18345413
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry.
Koga H; Zhang S; Kumanishi T; Washiyama K; Ichikawa T; Tanaka R; Mukawa J
Acta Neuropathol; 1994; 87(3):225-32. PubMed ID: 8009954
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
